Fig. 2From: Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophyIndividual responses to the question: ‘Would you agree to have your child take part in a potential trial if, in the absence of side-effects or with possible minimal side-effects, the prospect was to slow down a possible decline in motor function for at least two years?’Back to article page